Toronto Dominion Bank
PYXS icon

Toronto Dominion Bank’s Pyxis Oncology PYXS Stock Holding History

Toronto Dominion Bank’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$73K Sell
50,000
-25,000
-33% -$37.7K ﹤0.01% 1720
2025
Q4 		$86.3K Buy
+75,000
New +$265K ﹤0.01% 1588

Other funds holding PYXS

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
GGI
GordonMD Global Investments Beverely Hills, California $144M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Toronto Dominion Bank's PYXS Position: Q1 2026 in Review

Toronto Dominion Bank reduced its Pyxis Oncology (PYXS) stake by 33% in Q1 2026, selling an estimated $37.7K and leaving 50,000 shares worth $73K. The position accounts for ﹤0.01% of the portfolio, ranked #1720.

Toronto Dominion Bank first reported a position in PYXS in Q4 2025 and has held it in 2 quarters since. The position peaked at $86.3K in Q4 2025. 78 funds tracked by Wall St. Rank hold PYXS as of Q1 2026.

  • Toronto Dominion Bank held 50,000 shares of Pyxis Oncology worth $73K as of Q1 2026.
  • Toronto Dominion Bank sold 25,000 Pyxis Oncology shares in Q1 2026, an estimated $37.7K.
  • Pyxis Oncology made up ﹤0.01% of Toronto Dominion Bank's portfolio in Q1 2026, its #1720 holding.
  • Toronto Dominion Bank first reported a position in Pyxis Oncology in Q4 2025 and has held it in 2 quarters since.
  • Toronto Dominion Bank's Pyxis Oncology position peaked at $86.3K in Q4 2025.
  • 78 funds tracked by Wall St. Rank held Pyxis Oncology as of Q1 2026.

Based on Toronto Dominion Bank's 13F filing for Q1 2026, filed 15 May 2026.